BOTHELL, Wash.--(BUSINESS WIRE)--Sonus Pharmaceuticals, Inc. (NASDAQ: SNUS), an oncology drug development company, today announced that Alan Fuhrman, Senior Vice President and CFO, will present at the Washington Biotechnology and Biomedical Association (WBBA) Invest Northwest conference on Tuesday, March 20, 11:55 A.M. PT. The conference is being held in Seattle March 20-21.
